サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1477058

吸入麻酔の世界市場規模調査、タイプ別、エンドユーザー別、地域別予測：2022年～2032年

Global Inhalation Anesthesia Market Size study, by Type (Desflurane, Sevoflurane, Isoflurane, and Other Types), by End-User (Hospital, Ambulatory Surgical Centers, Other End Users), and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
吸入麻酔の世界市場規模調査、タイプ別、エンドユーザー別、地域別予測：2022年～2032年
出版日: 2024年05月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の吸入麻酔市場は、2023年には約13億米ドルと評価され、予測期間2024-2032年には4.57％以上の健全な成長率で成長すると予測されています。

揮発性麻酔薬としても知られる吸入麻酔薬は、全身麻酔や鎮静の開始と維持に不可欠であり、患者の安全性と手技の効率性が重視されるようになっています。主に吸入により投与されるが、静脈内投与や代替経路よりも実用的な利点があるため、麻酔レベルの正確なコントロールと迅速な調節が可能です。現在の主な吸入麻酔薬には、デスフルラン、セボフルラン、亜酸化窒素などがあり、手術量の増加や麻酔導入システムの進歩に後押しされています。特に、セボフルランの作用発現と回復時間の速さは、回復期間の短縮と患者の転帰の向上に対する要求と一致しています。この動向は、より安全で効率的な麻酔プロトコールへのシフトを強調し、現代の麻酔診療の状況を形成し、吸入麻酔技術の革新を推進しています。

世界の外科手術の増加は、高齢化社会とヘルスケアアクセスの拡大によって、吸入麻酔薬市場を推進しています。このような外科手術の急増は、選択的、非選択的を問わず、現代の麻酔診療の基本的な構成要素としての吸入麻酔薬に対する根強い需要を裏付けています。さらに、スマートモニタリングデバイスやクローズドループ麻酔システムなど、麻酔デリバリーシステムの技術的進歩が麻酔投与の安全性と精度を高め、市場の成長をさらに後押ししています。しかし、長時間の麻酔曝露による潜在的な副作用、医薬品承認に関する厳しい規制要件、ヘルスケアシステム内での価格圧力などの課題も残っています。しかし、現在進行中の研究開発は、リスクを軽減し、吸入麻酔薬の安全性と有効性のプロファイルを改善することを目的としており、その一方で、2022年から2032年にかけての吸入麻酔市場の成長は抑制されるであろう。

世界の吸入麻酔市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他世界の地域です。2023年には、吸入麻酔市場の市場シェアをリードする北米。この優位性は、革新的な吸入麻酔薬の研究開発への政府投資の増加と、この地域におけるがんの発生率の上昇によって促進されます。疾病の蔓延と疾病管理のための外科的介入の必要性は、市場成長を推進する追加要因です。例えば、カナダ政府の統計では、肺がん、乳がん、結腸直腸がん、前立腺がんなど、がんの診断と死亡率に関する憂慮すべき予測が明らかにされています。がんの罹患率が上昇するにつれ、低侵襲手術や開腹手術を含む外科治療の需要が高まり、吸入麻酔薬の需要を促進しています。このような要因の収束は、吸入麻酔市場の軌道を形成する上で北米が極めて重要な役割を担っていることを裏付けています。

本レポートに含まれる主な市場プレイヤー

  • Merck KGaA
  • アッヴィ社
  • バクスター・インターナショナル社
  • フレゼニウス・カビAG（Fresenius SE&Co.KGaA）
  • デクラ・ファーマシューティカルズ PLC（ハロカーボンライフサイエンス LLC）
  • ヒクマ・ファーマシューティカルズPLC
  • 江蘇恒瑞医薬有限公司（Jiangsu Hengrui Medicine Co.Ltd.）
  • 魯南医薬集団有限公司魯南薬業集団有限公司
  • ピラマール・エンタープライゼズ・リミテッド
  • 洛南薬業集団股有限公司

目次

第1章 世界の吸入麻酔市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 吸入麻酔の世界市場規模＆予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • タイプ別
    • エンドユーザー別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 世界の吸入麻酔市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 世界の吸入麻酔市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターの5フォースモデルへの未来的アプローチ
    • ポーター5フォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 吸入麻酔の世界市場規模・タイプ別予測：2022年～2032年

  • デスフルラン
  • セボフルラン
  • イソフルラン
  • その他のタイプ

第6章 吸入麻酔の世界市場規模・予測：エンドユーザー別、2022年～2032年

  • 病院
  • 外来手術センター
  • その他のエンドユーザー

第7章 吸入麻酔の世界市場吸入麻酔の世界市場規模・地域別予測、2022年～2032年

  • 北米の吸入麻酔市場
    • 米国
      • タイプ別内訳の市場規模＆予測、2022年～2032年
      • エンドユーザーの内訳サイズ＆予測、2022年～2032年
    • カナダの吸入麻酔市場
  • 欧州の吸入麻酔市場
    • 英国の吸入麻酔市場
    • ドイツの吸入麻酔市場
    • フランスの吸入麻酔市場
    • スペインの吸入麻酔市場
    • イタリアの吸入麻酔市場
    • その他欧州の吸入麻酔市場
  • アジア太平洋の吸入麻酔市場
    • 中国の吸入麻酔市場
    • インドの吸入麻酔市場
    • 日本の吸入麻酔市場
    • オーストラリアの吸入麻酔市場
    • 韓国の吸入麻酔市場
    • その他アジア太平洋の吸入麻酔市場
  • ラテンアメリカの吸入麻酔市場
    • ブラジルの吸入麻酔市場
    • メキシコの吸入麻酔市場
    • その他ラテンアメリカの吸入麻酔市場
  • 中東・アフリカの吸入麻酔市場
    • サウジアラビアの吸入麻酔市場
    • 南アフリカの吸入麻酔市場
    • その他中東・アフリカの吸入麻酔市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Merck KGaA
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • AbbVie Inc.
    • Baxter International Inc.
    • Fresenius Kabi AG（Fresenius SE& Co. KGaA）
    • Dechra Pharmaceuticals PLC（Halocarbon Life Sciences LLC）
    • Hikma Pharmaceuticals PLC
    • Jiangsu Hengrui Medicine Co. Ltd
    • Lunan Pharmaceutical Group Co. Ltd
    • Piramal Enterprises Limited
    • Troikaa Pharmaceuticals Ltd

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1.Global Inhalation Anesthesia market, report scope
  • TABLE 2.Global Inhalation Anesthesia Market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3.Global Inhalation Anesthesia Market estimates & forecasts by Type 2022-2032 (USD Billion)
  • TABLE 4.Global Inhalation Anesthesia Market estimates & forecasts by End-user 2022-2032 (USD Billion)
  • TABLE 5.Global Inhalation Anesthesia Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6.Global Inhalation Anesthesia Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7.Global Inhalation Anesthesia Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8.Global Inhalation Anesthesia Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9.Global Inhalation Anesthesia Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10.Global Inhalation Anesthesia Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11.Global Inhalation Anesthesia Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12.Global Inhalation Anesthesia Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13.Global Inhalation Anesthesia Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14.Global Inhalation Anesthesia Market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15.U.S. Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16.U.S. Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17.U.S. Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18.Canada Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 19.Canada Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20.Canada Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21.UK Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 22.UK Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23.UK Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24.Germany Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 25.Germany Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26.Germany Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27.France Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 28.France Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29.France Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30.Italy Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 31.Italy Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32.Italy Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33.Spain Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 34.Spain Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35.Spain Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36.RoE Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 37.RoE Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38.RoE Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39.China Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 40.China Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41.China Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42.India Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 43.India Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44.India Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45.Japan Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 46.Japan Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47.Japan Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48.Australia Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 49.Australia Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50.Australia Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51.South Korea Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 52.South Korea Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53.South Korea Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.
  • TABLE 55.RoAPAC Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 56.RoAPAC Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57.RoAPAC Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58.Brazil Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 59.Brazil Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60.Brazil Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61.Mexico Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 62.Mexico Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63.Mexico Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64.RoLA Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 65.RoLA Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66.RoLA Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67.Saudi Arabia Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68.Saudi Arabia Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69.Saudi Arabia Inhalation Anesthesia Market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70.South Africa Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 71.
  • TABLE 72.South Africa Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73.South Africa Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74.RoMEA Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75.RoMEA Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76.RoMEA Inhalation Anesthesia Market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77.List of secondary sources, used in the study of Global Inhalation Anesthesia Market.
  • TABLE 78.List of primary sources, used in the study of Global Inhalation Anesthesia Market.
  • TABLE 79.Years considered for the study.
  • TABLE 80.Exchange rates considered.

LIST OF FIGURES

  • FIG 1.Global Inhalation Anesthesia market, research methodology
  • FIG 2.Global Inhalation Anesthesia market, market estimation techniques
  • FIG 3.Global market size estimates & forecast methods.
  • FIG 4.Global Inhalation Anesthesia market, key trends 2023
  • FIG 5.Global Inhalation Anesthesia market, growth prospects 2022-2032
  • FIG 6.Global Inhalation Anesthesia market, porters 5 force model
  • FIG 7.Global Inhalation Anesthesia market, pestel analysis
  • FIG 8.Global Inhalation Anesthesia market, value chain analysis
  • FIG 9.Global Inhalation Anesthesia Market by segment, 2022 & 2032 (USD Billion)
  • FIG 10.Global Inhalation Anesthesia Market by segment, 2022 & 2032 (USD Billion)
  • FIG 11.Global Inhalation Anesthesia Market by segment, 2022 & 2032 (USD Billion)
  • FIG 12.Global Inhalation Anesthesia Market by segment, 2022 & 2032 (USD Billion)
  • FIG 13.Global Inhalation Anesthesia Market by segment, 2022 & 2032 (USD Billion)
  • FIG 14.Global Inhalation Anesthesia market, regional snapshot 2022 & 2032
  • FIG 15.North America Inhalation Anesthesia Market 2022 & 2032 (USD Billion)
  • FIG 16.Europe Inhalation Anesthesia Market 2022 & 2032 (USD Billion)
  • FIG 17.Asia pacific Inhalation Anesthesia Market 2022 & 2032 (USD Billion)
  • FIG 18.Latin America Inhalation Anesthesia Market 2022 & 2032 (USD Billion)
  • FIG 19.Middle East & Africa Inhalation Anesthesia Market 2022 & 2032 (USD Billion)
  • FIG 20.Global Inhalation Anesthesia market, company market share analysis (2023)
目次

Global Inhalation Anesthesia Market is valued at approximately USD 1.3 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.57% over the forecast period 2024-2032. Inhalational anesthetics, also known as volatile anesthetic agents, are essential in initiating and maintaining general anesthesia and sedation, with a growing emphasis on patient safety and procedural efficiency. Administered primarily via inhalation due to practical advantages over intravenous and alternative routes, they ensure precise control and rapid adjustment of anesthesia levels. Key inhalational anesthetics in current practice include desflurane, sevoflurane, and nitrous oxide, driven by increasing surgical volumes and advancements in anesthesia delivery systems. Particularly, sevoflurane's rapid onset of action and recovery time align with the demand for shorter recovery periods and enhanced patient outcomes. This trend underscores a shift towards safer and more efficient anesthesia protocols, shaping the landscape of modern anesthesia practice and driving innovation in inhalational anesthetic technologies.

The rise in surgical procedures globally is propelling the Inhalation Anesthetics Market, driven by an aging population, and expanded healthcare access. This surge in surgeries, both elective and non-elective, underscores the persistent demand for inhalational anesthetics as a fundamental component of modern anesthesia practice. Additionally, technological advancements in anesthesia delivery systems, such as smart monitoring devices and closed-loop anesthesia systems, are enhancing safety and precision in anesthesia administration, further boosting the market growth. However, challenges persist, including potential adverse effects of prolonged anesthesia exposure, stringent regulatory requirements for drug approval, and pricing pressures within healthcare systems. However, ongoing research and development efforts aim to mitigate risks and improve the safety and efficacy profile of inhalational anesthetics, on the other hand, will stifle Inhalation Anesthesia market growth between 2022 and 2032.

The key regions considered for the global Inhalation Anesthesia Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America leading the market share of the Inhalation Anesthesia Market. This dominance is fueled by increased government investment in research and development of innovative inhalation anesthetics, coupled with a rising incidence of cancer in the region. The prevalence of diseases and the necessity for surgical interventions for disease management are additional factors propelling market growth. For instance, statistics from the Government of Canada reveal alarming projections of cancer diagnoses and mortality rates, with lung, breast, colorectal, and prostate cancers being the most prevalent. As cancer incidence rises, the demand for surgical treatments, including minimally invasive and open surgeries, intensifies, thereby driving the demand for inhalation anesthetics. This convergence of factors underscores North America's pivotal role in shaping the trajectory of the Inhalation Anesthesia Market.

Major market player included in this report are:

  • Merck KGaA
  • AbbVie Inc.
  • Baxter International Inc.
  • Fresenius Kabi AG (Fresenius SE& Co. KGaA
  • Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd
  • Lunan Pharmaceutical Group Co. Ltd
  • Piramal Enterprises Limited
  • Troikaa Pharmaceuticals Ltd

The detailed segments and sub-segment of the market are explained below:

By Type

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Other Types

By End-user

  • Hospital
  • Ambulatory Surgical Centers
  • Other End Users

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Inhalation Anesthesia Market Definition and Research Assumptions

  • 1.1.Research Objective
  • 1.2.Market Definition
  • 1.3.Research Assumptions
    • 1.3.1.Inclusion & Exclusion
    • 1.3.2.Limitations
    • 1.3.3.Supply Side Analysis
      • 1.3.3.1.Availability
      • 1.3.3.2.Infrastructure
      • 1.3.3.3.Regulatory Environment
      • 1.3.3.4.Market Competition
      • 1.3.3.5.Economic Viability (Consumer's Perspective)
    • 1.3.4.Demand Side Analysis
      • 1.3.4.1.Regulatory frameworks
      • 1.3.4.2.Technological Advancements
      • 1.3.4.3.Environmental Considerations
      • 1.3.4.4.Consumer Awareness & Acceptance
  • 1.4.Estimation Methodology
  • 1.5.Years Considered for the Study
  • 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

  • 2.1.Global Inhalation Anesthesia Market Size & Forecast (2022- 2032)
  • 2.2.Regional Summary
  • 2.3.Segmental Summary
    • 2.3.1.By Type
    • 2.3.2.By End-user
  • 2.4.Key Trends
  • 2.5.Recession Impact
  • 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Inhalation Anesthesia Market Dynamics

  • 3.1.Market Drivers
  • 3.2.Market Challenges
  • 3.3.Market Opportunities

Chapter 4.Global Inhalation Anesthesia Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
    • 4.1.7.Porter's 5 Force Impact Analysis
  • 4.2.PESTEL Analysis
    • 4.2.1.Political
    • 4.2.2.Economical
    • 4.2.3.Social
    • 4.2.4.Technological
    • 4.2.5.Environmental
    • 4.2.6.Legal
  • 4.3.Top investment opportunity
  • 4.4.Top winning strategies
  • 4.5.Disruptive Trends
  • 4.6.Industry Expert Perspective
  • 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Inhalation Anesthesia Market Size & Forecasts by Type 2022-2032

  • 5.1.Desflurane
  • 5.2.Sevoflurane
  • 5.3.Isoflurane
  • 5.4.Other Types

Chapter 6.Global Inhalation Anesthesia Market Size & Forecasts by End-user 2022-2032

  • 6.1.Hospital
  • 6.2.Ambulatory Surgical Centers
  • 6.3.Other End Users

Chapter 7.Global Inhalation Anesthesia Market Size & Forecasts by Region 2022-2032

  • 7.1.North America Inhalation Anesthesia Market
    • 7.1.1.U.S. Inhalation Anesthesia Market
      • 7.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2.End-user breakdown size & forecasts, 2022-2032
    • 7.1.2.Canada Inhalation Anesthesia Market
  • 7.2.Europe Inhalation Anesthesia Market
    • 7.2.1.U.K. Inhalation Anesthesia Market
    • 7.2.2.Germany Inhalation Anesthesia Market
    • 7.2.3.France Inhalation Anesthesia Market
    • 7.2.4.Spain Inhalation Anesthesia Market
    • 7.2.5.Italy Inhalation Anesthesia Market
    • 7.2.6.Rest of Europe Inhalation Anesthesia Market
  • 7.3.Asia-Pacific Inhalation Anesthesia Market
    • 7.3.1.China Inhalation Anesthesia Market
    • 7.3.2.India Inhalation Anesthesia Market
    • 7.3.3.Japan Inhalation Anesthesia Market
    • 7.3.4.Australia Inhalation Anesthesia Market
    • 7.3.5.South Korea Inhalation Anesthesia Market
    • 7.3.6.Rest of Asia Pacific Inhalation Anesthesia Market
  • 7.4.Latin America Inhalation Anesthesia Market
    • 7.4.1.Brazil Inhalation Anesthesia Market
    • 7.4.2.Mexico Inhalation Anesthesia Market
    • 7.4.3.Rest of Latin America Inhalation Anesthesia Market
  • 7.5.Middle East & Africa Inhalation Anesthesia Market
    • 7.5.1. Saudi Arabia Inhalation Anesthesia Market
    • 7.5.2. South Africa Inhalation Anesthesia Market
    • 7.5.3.Rest of Middle East & Africa Inhalation Anesthesia Market

Chapter 8.Competitive Intelligence

  • 8.1.Key Company SWOT Analysis
  • 8.2.Top Market Strategies
  • 8.3.Company Profiles
    • 8.3.1. Merck KGaA
      • 8.3.1.1.Key Information
      • 8.3.1.2.Overview
      • 8.3.1.3.Financial (Subject to Data Availability)
      • 8.3.1.4.Product Summary
      • 8.3.1.5.Market Strategies
    • 8.3.2. AbbVie Inc.
    • 8.3.3.Baxter International Inc.
    • 8.3.4.Fresenius Kabi AG (Fresenius SE& Co. KGaA
    • 8.3.5.Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
    • 8.3.6.Hikma Pharmaceuticals PLC
    • 8.3.7.Jiangsu Hengrui Medicine Co. Ltd
    • 8.3.8.Lunan Pharmaceutical Group Co. Ltd
    • 8.3.9.Piramal Enterprises Limited
    • 8.3.10.Troikaa Pharmaceuticals Ltd

Chapter 9.Research Process

  • 9.1.Research Process
    • 9.1.1.Data Mining
    • 9.1.2.Analysis
    • 9.1.3.Market Estimation
    • 9.1.4.Validation
    • 9.1.5.Publishing
  • 9.2.Research Attributes